Reducing The Burden Of Patient Retention And Improving Continuity

See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.

Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

In this presentation, our expert panel introduces the concept of scaffolding — a targeted reinforcement strategy designed to strengthen trials from the inside out.

Understanding how a participant "feels" is essential for drug safety. Explore how subjective measures and specialized training provide the data needed to evaluate human abuse potential.

Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.

Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support.

Selecting the right functional service provider (FSP) is a critical factor in advancing clinical research programs efficiently, and this reimagined FSP model prioritizes each client’s unique objectives.

Learn about a unified ecosystem integrating eConsent, IRT, eCOA, and ePatient into a seamless workstream designed with a patient-centric approach.

Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.